COVID-19 treatments, QT interval, and arrhythmic risk: The need for an international registry on arrhythmias.

Crotti, Lia; Arbelo, Elena

Crotti, Lia; Arbelo, Elena.

Crotti L; Istituto Auxologico Italiano, IRCCS, Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Milan, Italy; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy; Istituto Auxologico Italiano, IRCCS, Center for Cardiac Arrhythmias of Genetic Origin, Milan, Italy. Electronic address: l.crotti@auxologico.it.
Arbelo E; Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Institut d'Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Heart Rhythm ; 17(9): 1423-1424, 2020 09.

Article in English | MEDLINE | ID: covidwho-421695

Subject(s)

Coronavirus Infections; Coronavirus; Pandemics; Pneumonia, Viral; Arrhythmias, Cardiac; Betacoronavirus; COVID-19; Coronavirus Infections/drug therapy; Electrocardiography; Humans; Registries; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Coronavirus / Pandemics Type of study: Prognostic study Limits: Humans Language: English Journal: Heart Rhythm Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google